Notably, CSCs and non-CSCs HCC demonstrate notable disparities in fatty acid metabolism, the PPAR signaling pathway, and the peroxisome proliferator-activated receptor pathway, indicating potential involvement of CSCs in lipid metabolism within the tumor tissue. The gene discussed is PPARA; the disease is hepatocellular carcinoma.